Cited by 2,020Schizophrenia research and treatmentNeurotransmitter Receptor Influence on BehaviorMental Health and Psychiatry

The DOI matches its Crossref record; 398 of the 399 references it cites were found in a registry or an index.

Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence

Harrison, P J, Weinberger, D R·2005·Molecular Psychiatry

DOI 10.1038/sj.mp.4001558

Open this paper in CoChat — free account

Abstract

This review critically summarizes the neuropathology and genetics of schizophrenia, the relationship between them, and speculates on their functional convergence. The morphological correlates of schizophrenia are subtle, and range from a slight reduction in brain size to localized alterations in the morphology and molecular composition of specific neuronal, synaptic, and glial populations in the hippocampus, dorsolateral prefrontal cortex, and dorsal thalamus. These findings have fostered the view of schizophrenia as a disorder of connectivity and of the synapse. Although attractive, such concepts are vague, and differentiating primary events from epiphenomena has been difficult. A way forward is provided by the recent identification of several putative susceptibility genes (including neuregulin, dysbindin, COMT, DISC1, RGS4, GRM3, and G72). We discuss the evidence for these and other genes, along with what is known of their expression profiles and biological roles in brain and how these may be altered in schizophrenia. The evidence for several of the genes is now strong. However, for none, with the likely exception of COMT, has a causative allele or the mechanism by which it predisposes to schizophrenia been identified. Nevertheless, we speculate that the genes may all converge functionally upon schizophrenia risk via an influence upon synaptic plasticity and the development and stabilization of cortical microcircuitry. NMDA receptor-mediated glutamate transmission may be especially implicated, though there are also direct and indirect links to dopamine and GABA signalling. Hence, there is a correspondence between the putative roles of the genes at the molecular and synaptic levels and the existing understanding of the disorder at the neural systems level. Characterization of a core molecular pathway and a 'genetic cytoarchitecture' would be a profound advance in understanding schizophrenia, and may have equally significant therapeutic implications.

Integrity signals

Registry

Crossref · 10.1038/sj.mp.4001558

Cites

398 of 398 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals
Jaenisch, R., & Bird, A. (2003) · Nature Genetics · doi:10.1038/ng1089 · Cited by 6,325
Implications of Normal Brain Development for the Pathogenesis of Schizophrenia
Weinberger, D. R. (1987) · Archives of General Psychiatry · doi:10.1001/archpsyc.1987.01800190080012 · Cited by 3,724
Self-citation
Recent advances in the phencyclidine model of schizophrenia
(1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.10.1301 · Cited by 2,904
Amyloid deposition as the central event in the aetiology of Alzheimer’s disease
Hardy, J., & Allsop, D. (1991) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(91)90609-v · Cited by 2,538
Effect of COMT Val 108/158 Met genotype on frontal lobe function and risk for schizophrenia
Egan, M. F., Goldberg, T. E., Kolachana, B. S., Callicott, J. H., Mazzanti, C. M., Straub, R. E., Goldman, D. A., & Weinberger, D. R. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.111134598 · Cited by 2,416
Self-citation
Schizophrenia as a Complex Trait: Evidence From a Meta-analysis of Twin Studies
Sullivan, P. F., Kendler, K. S., & Neale, M. C. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.12.1187 · Cited by 2,356
A review of MRI findings in schizophrenia
Shenton, M. E., Dickey, C. C., Frumin, M., & McCarley, R. W. (2001) · Schizophrenia Research · doi:10.1016/s0920-9964(01)00163-3 · Cited by 2,346
Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease
Lohmueller, K. E., Pearce, C. L., Pike, M., Lander, E. S., & Hirschhorn, J. N. (2003) · Nature Genetics · doi:10.1038/ng1071 · Cited by 1,900
Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders
Lachman, H. M., Papolos, D. F., Saito, T., Yu, Y.-M., Szumlanski, C. L., & Weinshilboum, R. M. (1996) · Pharmacogenetics · doi:10.1097/00008571-199606000-00007 · Cited by 1,788

Flagged first, then by citations

Show all 399 references

1 of the 399 references couldn’t be matched to a known paper.

Research works printed but not linked: 4

Grossman MH, Littrel JB, Weinstein R, Szumlanski C, Weinshilboum R . Identification of the possible basis for inherited differences in human catechol-O-methyltransferase. Trans Neurosci Soc 1992; 18: 70.
Straub RE, Egan MF, Hashimoto R, Matsumoto M, Weickert CS, Goldberg T et al. The schizophrenia susceptibility gene dysbindin (DTNBP1, 6p22.3): analysis of haplotypes, intermediate phenotypes, and alternative transcripts. Biol Psychiatry 2003; 53: 167S.
Callicott JH, Pezeawas L, Egan MF, Hariri AR, Mattay VS, Goldberg TE et al. Genetic variationVariation in DISC-1 affects hippocampal structure and function associated with increased risk for schizophrenia and with normal hippocampal structure and function. (in review).
Toro CT, Kasher PR, Deakin JFW . Altered D-serine metabolism in schizophrenia? A post-mortem study using Stanley Consortium brains [Abstract]. Schizophr Res 2004; 67(Suppl): 125.

Sorted by citations

Items 201–300 of 1,003

Translational perspectives for computational neuroimaging
Stephan, K. E., Iglesias, S., Heinzle, J., & Diaconescu, A. O. (2015) · Neuron · doi:10.1016/j.neuron.2015.07.008 · Cited by 169
Ketamine and phencyclidine: the good, the bad and the unexpected
Lodge, D., & Mercier, M. S. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13222 · Cited by 197
The pipeline and future of drug development in schizophrenia
Gray, J. A., & Roth, B. L. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4002062 · Cited by 182
Recent genetic findings in schizophrenia and their therapeutic relevance
Harrison, P. J. (2014) · Journal of Psychopharmacology · doi:10.1177/0269881114553647 · Cited by 201
Self-citation
Genetics of schizophrenia: new findings and challenges
Gejman, P. V., Sanders, A. R., & Kendler, K. S. (2011) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-082410-101459 · Cited by 183
DISC1 splice variants are upregulated in schizophrenia and associated with risk polymorphisms
Nakata, K., Lipska, B. K., Hyde, T. M., Ye, T., Newburn, E. N., Morita, Y., Vakkalanka, R., Barenboim, M., Sei, Y., Weinberger, D. R., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903413106 · Cited by 182
Self-citation
Mechanisms of action of second generation antipsychotic drugs in schizophrenia: insights from brain imaging studies
Abi-Dargham, A., & Laruelle, M. (2005) · European Psychiatry · doi:10.1016/j.eurpsy.2004.11.003 · Cited by 179
Mice lacking the AMPA GluR1 receptor exhibit striatal hyperdopaminergia and ‘schizophrenia-related’ behaviors
Wiedholz, L. M., Owens, W. A., Horton, R. E., Feyder, M. J., Karlsson, R.-M., Hefner, K. R., Sprengel, R., Celikel, T., Daws, L. C., & Holmes, A. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4002056 · Cited by 180
Differential developmental trajectories for CB1 cannabinoid receptor expression in limbic/associative and sensorimotor cortical areas
Heng, L., Beverley, J. A., Steiner, H., & Tseng, K. Y. (2010) · Synapse · doi:10.1002/syn.20844 · Cited by 180
Neuregulin1 (NRG1) Signaling through Fyn Modulates NMDA Receptor Phosphorylation: Differential Synaptic Function inNRG1+/−Knock-Outs Compared with Wild-Type Mice
Bjarnadóttir, M., Misner, D., Haverfield-Gross, S., Bruun, S., Helgason, V. G., Stefánsson, H., Sigmundsson, A., Firth, D. R., Nielsen, B., Stefansdottir, R., et al. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.4314-06.2007 · Cited by 176
d ‐Amino acid oxidase and serine racemase in human brain: normal distribution and altered expression in schizophrenia
Louise, V., Walker, M. A., Rawlings, N. B., Benzel, I. M., Kew, J. N. C., Harrison, P. J., & Burnet, P. W. J. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05769.x · Cited by 176
Self-citation
Recent progress in animal modeling of immune inflammatory processes in schizophrenia: Implication of specific cytokines
Nawa, H., & Takei, N. (2006) · Neuroscience Research · doi:10.1016/j.neures.2006.06.002 · Cited by 179
Specific Regulation of NRG1 Isoform Expression by Neuronal Activity
Liu, X., Bates, R. C., Yin, D., Shen, C., Wang, F., Su, N. Y., Kirov, S. A., Luo, Y., Wang, J.-Z., Xiong, W., et al. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.5317-10.2011 · Cited by 176
Synaptic plasticity impairment and hypofunction of NMDA receptors induced by glutathione deficit: Relevance to schizophrenia
Steullet, P., Neijt, H. C., Cuénod, M., & Do, K. Q. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2005.10.014 · Cited by 173
The neuregulin signaling pathway and schizophrenia: From genes to synapses and neural circuits
Buonanno, A. (2010) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2010.07.012 · Cited by 173
Epistasis between catechol- O -methyltransferase and type II metabotropic glutamate receptor 3 genes on working memory brain function
Tan, H. Y., Chen, Q., Sust, S., Buckholtz, J. W., Meyers, J. D., Egan, M. F., Mattay, V. S., Meyer‐Lindenberg, A., Weinberger, D. R., & Callicott, J. H. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610125104 · Cited by 174
Self-citation
Genetic variation in DTNBP1 influences general cognitive ability
Burdick, K. E., Lencz, T., Funke, B., Finn, C. T., Szeszko, P. R., Kane, J. M., Kucherlapati, R., & Malhotra, A. K. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddi481 · Cited by 173
The neurobiology of D-amino acid oxidase and its involvement in schizophrenia
Verrall, L., Burnet, P. W. J., Betts, J. F., & Harrison, P. J. (2009) · Molecular Psychiatry · doi:10.1038/mp.2009.99 · Cited by 173
Self-citation
Science and Recovery in Schizophrenia
Lieberman, J. A., Drake, R. E., Sederer, L. I., Belger, A., Keefe, R. S. E., Perkins, D. O., & Stroup, T. S. (2008) · Psychiatric Services · doi:10.1176/ps.2008.59.5.487 · Cited by 174
Neuregulin-1 Reverses Long-Term Potentiation at CA1 Hippocampal Synapses
Kwon, O., Longart, M., Vullhorst, D., Hoffman, D. A., & Buonanno, A. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.2100-05.2005 · Cited by 171
Kalirin regulates cortical spine morphogenesis and disease-related behavioral phenotypes
Cahill, M. E., Xie, Z., Day, M., Photowala, H., Barbolina, M. V., Miller, C. A., Weiss, C., Radulovic, J., Sweatt, J. D., Disterhoft, J. F., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0904636106 · Cited by 170
Influence of the NR3A subunit on NMDA receptor functions
Henson, M. A., Roberts, A. C., Pérez‐Otaño, I., & Philpot, B. D. (2010) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2010.01.004 · Cited by 195
Prefrontal-Hippocampal Coupling During Memory Processing Is Modulated by COMT Val158Met Genotype
Bertolino, A., Rubino, V., Sambataro, F., Blasi, G., Latorre, V., Fazio, L., Caforio, G., Petruzzella, V., Kolachana, B. S., Hariri, A. R., et al. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.03.078 · Cited by 174
Self-citation
Reflections on the Relationship Between Psychiatric Genetics and Psychiatric Nosology
Kendler, K. S. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.7.1138 · Cited by 169
Expression of DISC1 binding partners is reduced in schizophrenia and associated with DISC1 SNPs
Lipska, B. K., Peters, T., Hyde, T. M., Halim, N., Horowitz, C., Mitkus, S., Weickert, C. S., Matsumoto, M., Sawa, A., Straub, R. E., et al. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl040 · Cited by 168
Self-citation
Translating Glutamate: From Pathophysiology to Treatment
Javitt, D. C., Schoepp, D., Kalivas, P. W., Volkow, N. D., Zarate, C., Merchant, K., Bear, M. F., Umbricht, D., Hajos, M., Potter, W. Z., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002804 · Cited by 168
Functional gene group analysis identifies synaptic gene groups as risk factor for schizophrenia
the International Schizophrenia Consortium, Lips, E. S., Cornelisse, L. N., Toonen, R. F., Min, J. L., Hultman, C. M., Holmans, P. A., O'Donovan, M. C., Purcell, S. M., Smit, A. B., et al. (2012) · Molecular Psychiatry · doi:10.1038/mp.2011.117 · Cited by 167
Stereologic investigation of the posterior part of the hippocampus in schizophrenia
Schmitt, A., Steyskal, C., Bernstein, H., Schneider-Axmann, T., Parlapani, E., Schaeffer, E. L., Gattaz, W. F., Bogerts, B., Schmitz, C., & Falkai, P. (2008) · Acta Neuropathologica · doi:10.1007/s00401-008-0430-y · Cited by 167
Proteomic analysis of membrane microdomain-associated proteins in the dorsolateral prefrontal cortex in schizophrenia and bipolar disorder reveals alterations in LAMP, STXBP1 and BASP1 protein expression
Behan, Á., Byrne, C., Dunn, M. J., Cagney, G., & Cotter, D. R. (2009) · Molecular Psychiatry · doi:10.1038/mp.2008.7 · Cited by 145
Review: The group II metabotropic glutamate receptor 3 (mGluR3, mGlu3, GRM3): expression, function and involvement in schizophrenia
Harrison, P. J., Lyon, L., Sartorius, L. J., Burnet, P., & Lane, T. A. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881108089818 · Cited by 172
Self-citation
Anti-NMDA-receptor antibody detected in encephalitis, schizophrenia, and narcolepsy with psychotic features
Tsutsui, K., Kanbayashi, T., Tanaka, K., Boku, S., Ito, W., Tokunaga, J., Mori, A., Hishikawa, Y., Shimizu, T., & Nishino, S. (2012) · BMC Psychiatry · doi:10.1186/1471-244x-12-37 · Cited by 168
Assessment of Glutamate Transporter GLAST (EAAT1)-Deficient Mice for Phenotypes Relevant to the Negative and Executive/Cognitive Symptoms of Schizophrenia
Karlsson, R.-M., Tanaka, K., Saksida, L. M., Bussey, T. J., Heilig, M., & Holmes, A. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2008.215 · Cited by 165
Genetic association studies of glutamate, GABA and related genes in schizophrenia and bipolar disorder: A decade of advance
Cherlyn, S. Y. T., Woon, P. S., Liu, J., Ong, W., Tsai, G., & Sim, K. (2010) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2010.01.002 · Cited by 165
Neuroactive Steroids are Altered in Schizophrenia and Bipolar Disorder: Relevance to Pathophysiology and Therapeutics
Marx, C. E., Stevens, R. D., Shampine, L. J., Uzunova, V., Trost, W. T., Butterfield, M. I., Massing, M. W., Hamer, R. M., Morrow, A. L., & Lieberman, J. A. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300952 · Cited by 170
Increased Prefrontal and Hippocampal Glutamate Concentration in Schizophrenia: Evidence from a Magnetic Resonance Spectroscopy Study
van Elst, L. T., Valerius, G., Büchert, M., Thiel, T., Rüsch, N., Bubl, E., Hennig, J., Ebert, D., & Olbrich, H. M. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.04.041 · Cited by 164
Neuregulin-1 Modulates Hippocampal Gamma Oscillations: Implications for Schizophrenia
Fisahn, A., Neddens, J., Yan, L., & Buonanno, A. (2008) · Cerebral Cortex · doi:10.1093/cercor/bhn107 · Cited by 167
Using deep belief network modelling to characterize differences in brain morphometry in schizophrenia
Pinaya, W. H. L., Gadelha, A., Doyle, O., Noto, C. D. S., Zugman, A., Cordeiro, Q., Jackowski, A. P., Bressan, R. A., & Sato, J. R. (2016) · Scientific Reports · doi:10.1038/srep38897 · Cited by 164
Postnatal Phencyclidine Administration Selectively Reduces Adult Cortical Parvalbumin-Containing Interneurons
Wang, C. Z., Yang, S. F., Xia, Y., & Johnson, K. M. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301647 · Cited by 161
DTNBP1, a schizophrenia susceptibility gene, affects kinetics of transmitter release
Chen, X.-W., Feng, Y., Hao, C., Guo, X., He, X., Zhou, Z.-Y., Guo, N., Huang, H.-P., Xiong, W., Zheng, H., et al. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200711021 · Cited by 166
More Is Less: A Disinhibited Prefrontal Cortex Impairs Cognitive Flexibility
Gruber, A. J., Calhoon, G. G., Shusterman, I., Schoenbaum, G., Roesch, M. R., & O'Donnell, P. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.4623-10.2010 · Cited by 160
The use of neurophysiological endophenotypes to understand the genetic basis of schizophrenia
BRAFF, D. L., & Light, G. A. (2005) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2005.7.2/dlbraff · Cited by 161
Dopamine and psychosis: Theory, pathomechanisms and intermediate phenotypes
Tost, H., Alam, T., & Meyer-Lindenberg, A. (2010) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2009.06.005 · Cited by 160
NMDAR Hypofunction Animal Models of Schizophrenia
Lee, G. S., & Zhou, Y. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00185 · Cited by 168
Proteomic and genomic evidence implicates the postsynaptic density in schizophrenia
Föcking, M., Lopez, L. M., English, J. A., Dicker, P., Wolff, A., Brindley, E., Wynne, K. J., Cagney, G., & Cotter, D. (2014) · Molecular Psychiatry · doi:10.1038/mp.2014.63 · Cited by 156
Ras and Rap Signaling in Synaptic Plasticity and Mental Disorders
Stornetta, R. L., & Zhu, J. (2010) · The Neuroscientist · doi:10.1177/1073858410365562 · Cited by 161
Neural basis of psychosis-related behaviour in the infection model of schizophrenia
Meyer, U., & Feldon, J. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.12.022 · Cited by 158
Glutamatergic abnormalities in schizophrenia: A review of proton MRS findings
Poels, E. M. P., Kegeles, L. S., Kantrowitz, J. T., Javitt, D. C., Lieberman, J. A., Abi‐Dargham, A., & Girgis, R. R. (2014) · Schizophrenia Research · doi:10.1016/j.schres.2013.12.013 · Cited by 158
Dendritic spine dynamics--a key role for kalirin-7
Penzes, P., & Jones, K. A. (2008) · Trends in Neurosciences · doi:10.1016/j.tins.2008.06.001 · Cited by 157
AKT1 Is Associated with Schizophrenia Across Multiple Symptom Dimensions in the Irish Study of High Density Schizophrenia Families
Thiselton, D. L., Vladimirov, V. I., Kuo, P., McClay, J. L., Wormley, B., Fanous, A. H., O’Neill, F. A., Walsh, D., van den Oord, E. J. C. G., Kendler, K. S., et al. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.06.005 · Cited by 156
A haplotype within the DISC1 gene is associated with visual memory functions in families with a high density of schizophrenia
Hennah, W., Tuulio‐Henriksson, A., Paunio, T., Ekelund, J., Varilo, T., Partonen, T., Cannon, T. D., Lönnqvist, J. K., & Peltonen, L. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001731 · Cited by 156
BASAL GANGLIA PATHOLOGY IN SCHIZOPHRENIA: DOPAMINE CONNECTIONS and ANOMALIES
Pérez‐Costas, E., Meléndez‐Ferro, M., & Roberts, R. C. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06604.x · Cited by 149
Modelling prefrontal cortex deficits in schizophrenia: implications for treatment
Pratt, J. A., Winchester, C. L., Egerton, A., Cochran, S., & Morris, B. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.24 · Cited by 154
Similar immune profile in bipolar disorder and schizophrenia: selective increase in soluble tumor necrosis factor receptor I and von Willebrand factor
Hope, S., Melle, I. S., Aukrust, P., Steen, N. E., Birkenaes, A. B., Lorentzen, S., Agartz, I., Ueland, T., & Andreassen, O. A. (2009) · Bipolar Disorders · doi:10.1111/j.1399-5618.2009.00757.x · Cited by 155
Molecular Cloning of a Brain-specific, Developmentally Regulated Neuregulin 1 (NRG1) Isoform and Identification of a Functional Promoter Variant Associated with Schizophrenia
Tan, W., Wang, Y., Gold, B., Chen, J., Dean, M. C., Harrison, P. J., Weinberger, D. R., & Law, A. J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m702953200 · Cited by 153
Self-citation
Glutamate signaling in the pathophysiology and therapy of schizophrenia
Lin, C., Lane, H., & Tsai, G. E. (2011) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.03.023 · Cited by 154
Antipsychotic drugs activate SREBP-regulated expression of lipid biosynthetic genes in cultured human glioma cells: a novel mechanism of action?
Fernø, J., Raeder, M. B., Vik‐Mo, A. O., Skrede, S., Glambek, M., Tronstad, K. J., Breilid, H., Løvlie, R., Berge, R. K., Stansberg, C. T., et al. (2005) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500323 · Cited by 152
GABA and glutamate in schizophrenia: A 7 T 1H-MRS study
Marsman, A., Mandl, R. C. W., Klomp, D. W. J., Bohlken, M. M., Boer, V. O., Андрейченко, А. Е., Cahn, W., Kahn, R. S., Luijten, P. R., & Pol, H. E. H. (2014) · NeuroImage Clinical · doi:10.1016/j.nicl.2014.10.005 · Cited by 159
NMDA receptor subunit NRI and postsynaptic protein PSD-95 in hippocampus and orbitofrontal cortex in schizophrenia and mood disorder
Toro, C. T., & Deakin, J. F. W. (2005) · Schizophrenia Research · doi:10.1016/j.schres.2005.07.003 · Cited by 153
Susceptibility genes for schizophrenia: Characterisation of mutant mouse models at the level of phenotypic behaviour
O’Tuathaigh, C. M. P., Babovic, D., O’Meara, G. F., Clifford, J. J., Croke, D. T., & Waddington, J. L. (2006) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2006.04.002 · Cited by 154
The association between the Val158Met polymorphism of the catechol-O-methyl transferase gene and morphological abnormalities of the brain in chronic schizophrenia
Ohnishi, T., Hashimoto, R., Mori, T., Nemoto, K., Moriguchi, Y., Iida, H., Noguchi, H., Nakabayashi, T., Hori, H., Ohmori, M., et al. (2005) · Brain · doi:10.1093/brain/awh702 · Cited by 151
Prenatal viral infection in mouse causes differential expression of genes in brains of mouse progeny: A potential animal model for schizophrenia and autism
Fatemi, S. H., Pearce, D. A., Brooks, A. I., & Sidwell, R. W. (2005) · Synapse · doi:10.1002/syn.20162 · Cited by 151
Genetics and intermediate phenotypes of the schizophrenia—bipolar disorder boundary
Ivleva, E. I., Morris, D. W., Moates, A. F., Suppes, T. M., Thaker, G. K., & Tamminga, C. A. (2009) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2009.11.022 · Cited by 159
Mean diffusivity and fractional anisotropy as indicators of disease and genetic liability to schizophrenia
Clark, K. A., Nuechterlein, K. H., Asarnow, R. F., Hamilton, L. S., Phillips, O. R., Hageman, N. S., Woods, R. P., Alger, J. R., Toga, A. W., & Narr, K. L. (2011) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2011.01.006 · Cited by 149
Influence of Functional Variant of Neuronal Nitric Oxide Synthase on Impulsive Behaviors in Humans
Reif, A., Jacob, C., Rujescu, D., Herterich, S., Lang, S., Gutknecht, L., Baehne, C. G., Strobel, A., Freitag, C. M., Giegling, I., et al. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2008.510 · Cited by 151
Variation at the DAOA/G30 Locus Influences Susceptibility to Major Mood Episodes but Not Psychosis in Schizophrenia and Bipolar Disorder
Williams, N. M., Green, E., MacGregor, S., Dwyer, S., Norton, N., Williams, H. J., Raybould, R., Grozeva, D., Hamshere, M. L., Zammit, S., et al. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.4.366 · Cited by 148
Differential effects of prenatal and postnatal expressions of mutant human DISC1 on neurobehavioral phenotypes in transgenic mice: evidence for neurodevelopmental origin of major psychiatric disorders
Ayhan, Y., Abazyan, B., Nomura, J., Kim, R., Ladenheim, B., Krasnova, I. N., Sawa, A., Margolis, R. L., Cadet, J. L., Mori, S., et al. (2011) · Molecular Psychiatry · doi:10.1038/mp.2009.144 · Cited by 148
Neuregulin 1-ErbB4-PI3K signaling in schizophrenia and phosphoinositide 3-kinase-p110δ inhibition as a potential therapeutic strategy
Law, A. J., Wang, Y., Sei, Y., O’Donnell, P., Piantadosi, P., Papaleo, F., Straub, R. E., Huang, W., Thomas, C. J., Vakkalanka, R., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1206118109 · Cited by 147
Self-citation
Symptom rating scales and outcome in schizophrenia
Mortimer, A. M. (2007) · The British Journal of Psychiatry · doi:10.1192/bjp.191.50.s7 · Cited by 150
A Diffusion Tensor Imaging Study of White Matter in Early-Onset Schizophrenia
Kyriakopoulos, M., Vyas, N. S., Barker, G. J., Chitnis, X. A., & Frangou, S. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.05.021 · Cited by 149
Dysbindin-1 is a synaptic and microtubular protein that binds brain snapin
Talbot, K., Cho, D.-S., Ong, W., Benson, M. A., Han, L.-Y., Kazi, H., Kamins, J., Hahn, C.-G., Blake, D. J., & Arnold, S. E. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl246 · Cited by 148
Minocycline as Adjunctive Therapy for Schizophrenia: An Open-Label Study
Miyaoka, T., Yasukawa, R., Yasuda, H., Hayashida, M., Inagaki, T., & Horiguchi, J. (2008) · Clinical Neuropharmacology · doi:10.1097/wnf.0b013e3181593d45 · Cited by 146
Maternal Immune Activation during Gestation Interacts withDisc1Point Mutation to Exacerbate Schizophrenia-Related Behaviors in Mice
Lipina, T. V., Zai, C. C. H., Hlousek, D., Roder, J., & Wong, A. H. C. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.0091-13.2013 · Cited by 156
Schizophrenia and epilepsy: Is there a shared susceptibility?
Cascella, N. G., Schretlen, D. J., & Sawa, A. (2009) · Neuroscience Research · doi:10.1016/j.neures.2009.01.002 · Cited by 146
Evidence for abnormalities of cortical development in adolescent-onset schizophrenia
Voets, N., Hough, M., Douaud, G., Matthews, P. M., James, A. C., Winmill, L., Webster, P., & Smith, S. M. (2008) · NeuroImage · doi:10.1016/j.neuroimage.2008.08.013 · Cited by 145
Synaptic Wnt signaling—a contributor to major psychiatric disorders?
Okerlund, N. D., & Cheyette, B. N. R. (2011) · Journal of Neurodevelopmental Disorders · doi:10.1007/s11689-011-9083-6 · Cited by 149
Abnormal Trajectories of Neurodevelopment and Behavior Following In Utero Insult in the Rat
Piontkewitz, Y., Arad, M., & Weiner, I. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.06.007 · Cited by 152
Mismatch Negativity in First-Episode Schizophrenia
Haigh, S. M., Coffman, B. A., & Salisbury, D. F. (2016) · Clinical EEG and Neuroscience · doi:10.1177/1550059416645980 · Cited by 152
Interaction between serotonin transporter gene, catechol-O-methyltransferase gene and stressful life events in mood disorders
Mandelli, L., Serretti, A., Marino, E., Pirovano, A., Calati, R., & Colombo, C. (2006) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145706006882 · Cited by 143
A Neonatal Ventral Hippocampal Lesion Causes Functional Deficits in Adult Prefrontal Cortical Interneurons
Tseng, K. Y., Lewis, B. L., Hashimoto, T., Sesack, S. R., Kloc, M., Lewis, D. A., & O'Donnell, P. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.4166-08.2008 · Cited by 144
Vitamin D in fetal brain development
Eyles, D. W., Burne, T. H. J., & McGrath, J. J. (2011) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2011.05.004 · Cited by 146
Significance of vitamin A to brain function, behavior and learning
Olson, C. R., & Mello, C. V. (2010) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200900246 · Cited by 148
Antipsychotic-induced tardive dyskinesia and polymorphic variations in COMT, DRD2, CYP1A2 and MnSOD genes: a meta-analysis of pharmacogenetic interactions
Bakker, P. R., van Harten, P. N., & van Os, J. (2008) · Molecular Psychiatry · doi:10.1038/sj.mp.4002142 · Cited by 143
Developmental disruptions in neural connectivity in the pathophysiology of schizophrenia
Karlsgodt, K. H., Sun, D., Jimenez, A. M., Lutkenhoff, E. S., Willhite, R., van Erp, T. G. M., & Cannon, T. D. (2008) · Development and Psychopathology · doi:10.1017/s095457940800062x · Cited by 149
2‐D DIGE analysis implicates cytoskeletal abnormalities in psychiatric disease
English, J. A., Dicker, P., Föcking, M., Dunn, M. J., & Cotter, D. (2009) · PROTEOMICS · doi:10.1002/pmic.200900015 · Cited by 146
Disrupted-in-schizophrenia 1 (DISC1) plays essential roles in mitochondria in collaboration with Mitofilin
Park, Y.-U., Jeong, J., Lee, H., Mun, J. Y., Kim, J.-H., Lee, J. S., Nguyen, M. D., Han, S. S., Suh, P.-G., & Park, S. K. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1004361107 · Cited by 143
Gene regulation by hypoxia and the neurodevelopmental origin of schizophrenia
Schmidt‐Kastner, R., van Os, J., Steinbusch, H. W. M., & Schmitz, C. (2006) · Schizophrenia Research · doi:10.1016/j.schres.2006.02.022 · Cited by 146
Evidence for statistical epistasis between catechol-O-methyltransferase (COMT) and polymorphisms in RGS4, G72 (DAOA), GRM3, and DISC1: influence on risk of schizophrenia
Nicodemus, K. K., Kolachana, B. S., Vakkalanka, R., Straub, R. E., Giegling, I., Egan, M. F., Rujescu, D., & Weinberger, D. R. (2006) · Human Genetics · doi:10.1007/s00439-006-0257-3 · Cited by 145
Self-citation
Early Visual Sensory Deficits as Endophenotypes for Schizophrenia
Yeap, S., Kelly, S. P., Sehatpour, P., Magno, E., Javitt, D. C., Garavan, H., Thakore, J. H., & Foxe, J. J. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.11.1180 · Cited by 147
Glutamatergic dysfunction in schizophrenia: From basic neuroscience to clinical psychopharmacology
Paz, R. D., Tardito, S., Atzori, M., & Tseng, K. Y. (2008) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2008.06.005 · Cited by 145
Pregnenolone as a novel therapeutic candidate in schizophrenia: emerging preclinical and clinical evidence
Marx, C. E., Bradford, D. W., Hamer, R. M., Naylor, J. C., Allen, T. B., Lieberman, J. A., Strauss, J. L., & Kilts, J. D. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.06.076 · Cited by 142
Genetics of Antipsychotic Treatment Emergent Weight Gain in Schizophrenia
Müller, D. J., & Kennedy, J. L. (2006) · Pharmacogenomics · doi:10.2217/14622416.7.6.863 · Cited by 139
Updating hippocampal representations: CA2 joins the circuit
Jones, M. W., & McHugh, T. J. (2011) · Trends in Neurosciences · doi:10.1016/j.tins.2011.07.007 · Cited by 147
The Complement System in Schizophrenia
Mayilyan, K. R., Weinberger, D. R., & Sim, R. B. (2008) · Drug News & Perspectives · doi:10.1358/dnp.2008.21.4.1213349 · Cited by 139
Self-citation
Reduced Laterality as a Trait Marker ofSchizophrenia—Evidence from Structural and Functional Neuroimaging
Oertel, V., Knöchel, C., Rotarska-Jagiela, A., Schönmeyer, R., Lindner, M., van de Ven, V. G., Haenschel, C., Uhlhaas, P. J., Maurer, K., & Linden, D. E. J. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.4575-09.2010 · Cited by 145
Towards understanding the schizophrenia code: an expanded convergent functional genomics approach
Le‐Niculescu, H., Balaraman, Y., Patel, S., Tan, J., Sidhu, K., Jerome, R. E., Edenberg, H. J., Kuczenski, R., Geyer, M. A., Nurnberger, J. I., et al. (2007) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30481 · Cited by 137
Combined effect of neonatal immune activation and mutant DISC1 on phenotypic changes in adulthood
Ibi, D., Nagai, T., Koike, H., Kitahara, Y., Mizoguchi, H., Niwa, M., Jaaro-Peled, H., Nitta, A., Yoneda, Y., & Nabeshima, T. (2010) · Behavioural Brain Research · doi:10.1016/j.bbr.2009.08.027 · Cited by 137
Microglia and Brain Plasticity in Acute Psychosis and Schizophrenia Illness Course: A Meta-Review
Picker, L. D., Morrens, M., Chance, S. A., & Boche, D. (2017) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2017.00238 · Cited by 138
A Neuron-Optimized CRISPR/dCas9 Activation System for Robust and Specific Gene Regulation
Savell, K. E., Bach, S. V., Zipperly, M. E., Revanna, J. S., Goska, N. A., Tuscher, J. J., Duke, C. G., Sultan, F. A., Burke, J. N., Williams, D., et al. (2019) · eNeuro · doi:10.1523/eneuro.0495-18.2019 · Cited by 137
Myelin, myelin-related disorders, and psychosis
Mighdoll, M. I., Tao, R., Kleinman, J. E., & Hyde, T. M. (2015) · Schizophrenia Research · doi:10.1016/j.schres.2014.09.040 · Cited by 135
Neonatal polyI:C treatment in mice results in schizophrenia-like behavioral and neurochemical abnormalities in adulthood
Ibi, D., Nagai, T., Kitahara, Y., Mizoguchi, H., Koike, H., Shiraki, A., Takuma, K., Kamei, H., Noda, Y., Nitta, A., et al. (2009) · Neuroscience Research · doi:10.1016/j.neures.2009.03.015 · Cited by 135

Authors: Harrison, P. J., & Weinberger, D. R.
Affiliations: Warneford Hospital (GB)
National Institutes of Health (US)
ORCID: Harrison, P J
Weinberger, D R
Venue: Molecular Psychiatry
Publisher: Springer Science and Business Media LLC
Published: 2004-07-20
Volume: 10
Issue: 1
Pages: 40-68
ISSN: 1359-4184 (ISSN-L)
1476-5578
DOI: 10.1038/sj.mp.4001558
OpenAlex: W2071090720
Cited by: 2,020
References: 399
Citations by year: 2026: 10 · 2025: 20 · 2024: 22 · 2023: 38 · 2022: 38 · 2021: 34 · 2020: 34 · 2019: 42 · 2018: 52 · 2017: 58 · 2016: 66 · 2015: 88 · 2014: 102 · 2013: 92 · 2012: 129
FWCI: 22.22
Type: journal article
Language: en
Update notices: erratum (2005-03-29)
Open access: closed
Licence: www.springer.com/tdm (tdm)
www.springer.com/tdm (vor)
Locations: Molecular Psychiatry (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
Social Sciences › Arts and Humanities › Philosophy › Mental Health and Psychiatry
Keywords: schizophrenia, schizophrenia genetics, susceptibility genes, gene expression, synaptic plasticity, cortical microcircuitry, NMDA receptor, glutamatergic neurotransmission, dopamine signalling, GABA signalling, neuregulin, dysbindin, catechol-O-methyltransferase, DISC1, RGS4, GRM3, G72, hippocampus, dorsolateral prefrontal cortex, dorsal thalamus, brain connectivity
MeSH terms: Dysbindin, Brain, Carrier Proteins, Catechol O-Methyltransferase, Gene Expression Regulation, Humans, Schizophrenia, Genetic Predisposition to Disease, Neuregulin-1, Dystrophin-Associated Proteins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks